Worldwide Clinical Trials
Danielle Mylchreest MRQA has a diverse work experience in the field of quality assurance. Their most recent role was as a Director Therapeutic Area Quality Lead at Worldwide Clinical Trials, where they started in August 2023. Prior to that, they worked as an Associate Director Therapeutic Area Quality Lead at the same company from September 2021 to August 2023. Danielle also worked as a Senior Quality Study Representative at Worldwide Clinical Trials from June 2021 to September 2021.
Before joining Worldwide Clinical Trials, Danielle worked at MEU SOLUTIONS LTD as the Head of Quality Assurance from April 2021 to June 2021, and as a Quality Assurance Officer from July 2015 to April 2021. Danielle also worked at Medicines Evaluation Unit Ltd as the Head of Quality Assurance from April 2021 to June 2021, as a Quality Manager from April 2018 to April 2021, and as a Quality Assurance Officer from September 2014 to April 2018.
Danielle's early career includes a role as a Quality Assurance Officer at Nicoventures from April 2013 to September 2014, and as a Research Assistant at Kidscan Children's Cancer Research from June 2011 to June 2013.
Danielle Mylchreest MRQA completed a Bachelor of Science (BS) degree in Biomedical Sciences, General from The University of Salford between 2009 and 2013. Later, in 2017 and 2018, Danielle pursued the Q3P Programme at UCL without a specified degree name.
This person is not in any teams
This person is not in any offices
Worldwide Clinical Trials
11 followers
About Worldwide Clinical Trials Worldwide Clinical Trials is a leading full-service global contract research organization (CRO) that works in partnership with biotechnology and pharmaceutical companies to create customized solutions that advance new treatments. Our capabilities include bioanalytical laboratory services, Phase I-IV clinical trials, and post-approval and real-world evidence studies – all powered by our team members who bring their expertise and a collaborative, personalized approach to each clinical program. Anchored in our company’s scientific heritage, our dedicated therapeutic focus on cardiovascular, metabolic, neuroscience, oncology, and rare diseases, is applied to develop flexible plans and solve problems quickly for our customers. Our talented team of 3,000+ professionals spans 60+ countries, and embraces a culture of diversity, equity, inclusion, and belonging (DEI&B). We are united in cause with our customers to improve the lives of patients through new, innovative therapies. For more information on Worldwide, visit www.Worldwide.com.